Filter Results
:
(87)
Show Results For
-
All HBS Web
(180)
- News (48)
- Research (87)
- Events (2)
- Multimedia (3)
- Faculty Publications (46)
Show Results For
-
All HBS Web
(180)
- News (48)
- Research (87)
- Events (2)
- Multimedia (3)
- Faculty Publications (46)
Sort by
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby largely preserving View Details
Keywords:
Dina Gerdeman
- 05 Jun 2009
- Research Event
Business Summit: Niall Ferguson and the Certainty of Uncertainty
based on the map that is used. Optimized global networks may be vulnerable to crises. Business and political leaders are often surprised by crises; they don't take a long enough view of history. Biological evolution is a metaphor for the...
View Details
Keywords:
Re: John A. Quelch
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
timed experiments—like biological and chemical fields—research time slid 30 to 40 percent. Overall, 55 percent of the respondents reported a decline in total work hours, 27 percent indicated no change, and 18 percent said they were...
View Details
- 14 Jul 2015
- First Look
First Look: July 14, 2015
In press Journal of Experimental Psychology: General Hormones and Ethics: Understanding the Biological Basis of Unethical Conduct By: Lee, Jooa Julia, Francesca Gino, Ellie Shuo Jin, Leslie K. Rice, and Robert A. Josephs...
View Details
Keywords:
Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering...
View Details
Keywords:
Sean Silverthorne
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how...
View Details
Keywords:
Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
Sigman Abstract—We study desensitization to crime in a lab experiment by showing footage of criminal acts to a group of subjects, some of whom have been previously victimized. We measure biological markers of stress and behavioral indices...
View Details
Keywords:
Sean Silverthorne
- 01 May 2007
- First Look
First Look: May 1, 2007
(along with personal relations), laws and regulations can evolve to facilitate real estate investments. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207090 The Convention on Biological Diversity:...
View Details
Keywords:
Sean Silverthorne
- 31 May 2011
- First Look
First Look: May 31
confident of the market potential for mobile payments, they recognized the challenges they faced in scaling their current business model. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/811029-PDF-ENG Office of Technology Transfer—Shanghai Institutes for View Details
Keywords:
Sean Silverthorne
- 11 Sep 2007
- First Look
First Look: September 11, 2007
developing proven molecules from strategic partners to leapfrog competition and create large molecule biologics in India. The company understood that its transition from an API to an innovation-led company focused on new View Details
Keywords:
Martha Lagace
- 07 Aug 2018
- First Look
New Research and Ideas, August 8, 2018
Free Speech at Google In August 2017, Google fired James Damore, a 28-year-old software engineer who had been employed by the company since 2013. The move came after Damore penned an internal company memo titled “Google’s Ideological Echo Chamber,” which posited that...
View Details
Keywords:
by Sean Silverthorne
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
responsible for the safety and effectiveness of prescription drugs, biologics (biotech products derived from living sources such as cells), over-the-counter medicines, medical devices, cosmetics, nutritional supplements, and all food...
View Details
- 30 Sep 2019
- Book
Book Excerpt: Why a Volume on Race, Work, and Leadership
construction of blackness has been an economic tool for centuries; it has been used as a means of sourcing under- or wholly unpaid labor, rationalized by an attribution of blacks’ biological inferiority. Though research has since amassed...
View Details
Keywords:
Re: Gerardine A. Doyle
- 05 Dec 2013
- What Do You Think?
Is Walmart Defying Economic Gravity?
Original Article There is a body of research that seeks to relate economics to human biology. It's usually associated with the notion that the life cycles of businesses parallel stages of biological life: birth, rapid growth, maturity,...
View Details
- 07 Sep 2016
- What Do You Think?
How Can the Threat of Networks Be Reduced?
networks as we know them, with their devices, will cease to exist within the next decade. These bit based clod machines will yield to a kind of biologic environment, where the systems are secondary to the need constantly adapting and...
View Details
Keywords:
by James Heskett
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already approved original View Details
Keywords:
Sean Silverthorne
- 20 Mar 2012
- First Look
First Look: March 20
through a largely unguided process like biological evolution with a gradual impact upon the distribution of power among economic and political actors, the emergence of factor markets typically required fundamental reordering of power...
View Details
Keywords:
Sean Silverthorne
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
the threshold for research and development (R&D) investment in an economically viable product. Further, the small size of patient populations for orphan drugs, together with the increasing prevalence of biologics among orphan drugs,...
View Details
Keywords:
Dina Gerdeman
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
product upon entry, however only a few biosimilars have been approved in the U.S. since 2015, thereby largely preserving biologics from competition. We analyze European markets, which have had biosimilar competition since 2006. Using our...
View Details
Keywords:
Sean Silverthorne
- 12 Mar 2013
- First Look
First Look: March 12
bottleneck. Historically, prize-based contests have had striking success in attracting unconventional individual who can overcome difficult challenges. To determine whether this approach could solve a real big-data biologic algorithm...
View Details
Keywords:
Sean Silverthorne